Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 22.33%, near the low end of its 5-year range (0.00%–64.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 41.23%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
41.23%
DEBT TO ASSETS RATIO AVG 3Y
33.80%
DEBT TO ASSETS RATIO AVG 5Y
22.33%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$44.95M
Debt to Assets Ratio
0.00%
TTM Avg
41.23%
3Y Avg
33.80%
5Y Avg
22.33%
Market Cap
$44.67M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.82M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$47.29M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.81M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $44.95M | 0.00% | 41.23% | 33.80% | 22.33% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.67M | 0.08% | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.37M | 0.34% | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.82M | 0.03% | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.29M | 0.00% | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.81M | 0.00% | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $41.56M | 0.64% | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.63M | 0.61% | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $48.81M | 0.97% | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | 0.22% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
2.91
Interest Coverage
-11.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 64.89% |
| 2025-12-31 | 54.28% |
| 2025-09-30 | 46.84% |
| 2025-06-30 | 40.13% |
| 2025-03-31 | 34.52% |
| 2024-12-31 | 29.22% |
| 2024-09-30 | 26.26% |
| 2024-06-30 | 23.86% |
| 2024-03-31 | 28.87% |
| 2023-12-31 | 29.70% |
| 2023-09-30 | 29.59% |
| 2023-06-30 | 28.51% |
| 2023-03-31 | 27.30% |
| 2022-12-31 | 9.16% |
| 2022-09-30 | 8.79% |
| 2022-06-30 | 8.87% |
| 2022-03-31 | 9.56% |
| 2021-12-31 | 8.74% |
| 2021-09-30 | 1.14% |
| 2021-06-30 | 1.16% |
| 2021-03-31 | 2.66% |
| 2020-12-31 | 2.64% |
